4 recruiting, 1 active not recruiting. 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Recruiting 2 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Lynch Syndrome II: new trials by email Literature Review of Lynch Syndrome II trials Research Report on Lynch Syndrome II
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch Syndrome Sampling of suspected skin lesions (in accordance with good care practices)., Constitution of a biobank - Basal Cell Carcinoma of Skin, Site Unspecified, Epidermoid Carcinoma | Not applicable | Recruiting | Centre Hospitalier Universitaire de Nīmes | 150 | 2026-03-13 | 2026-06-22 |
| Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection BEACON - Colorectal Cancer, Adenoma Colon | Recruiting | San Raffaele University | 1200 | 2024-01-01 | 2026-03-04 | |
| Lynch Syndrome X-Talk of Enteral Mucosa With Immune System LYNX EYE (Lynch syndrome X-Talk of Enteral mucosa with Immune System) - Lynch Syndrome, Lynch Syndrome I | Recruiting | San Raffaele University | 300 | 2023-06-01 | 2026-04-24 | |
| Videocapsule Endoscopy in Lynch Syndrome Video capsule endoscopy - Lynch Syndrome, Lynch Syndrome I | Not applicable | Recruiting | San Raffaele University | 100 | 2018-11-01 | 2026-04-22 |
| Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers Biopsy Procedure, Biospecimen Collection, Computed Tomography - Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 68 | 2017-09-27 | 2026-08-13 |
Colorectal Neoplasms, Hereditary Nonpolyposis (4) · Carcinoma, Basal Cell (2) · Colorectal Neoplasms (2) · Lynch syndrome I (site-specific colonic cancer) (2) · Muir-Torre Syndrome (2) · Turcot syndrome (2) · Adenocarcinoma, Papillary (1) · Carcinoma (1) · Carcinoma, Basosquamous (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Signet Ring Cell (1) · Carcinoma, Squamous Cell (1) · Colonic Diseases (1) · Colonic Neoplasms (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Genetic Diseases, Inborn (5) · Neoplasms (5) · Neoplasms by Site (5) · DNA Repair-Deficiency Disorders (4) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Gastrointestinal Diseases (4) · Gastrointestinal Neoplasms (4) · Intestinal Diseases (4) · Intestinal Neoplasms (4) · Metabolic Diseases (4) · Neoplastic Syndromes, Hereditary (4) · Nutritional and Metabolic Diseases (4) · Colonic Diseases (3)
Biopsy (1) · Capsule Endoscopy (1) · Nivolumab (1) · Specimen Handling (1) · talimogene laherparepvec (1)
San Raffaele University (3) · Centre Hospitalier Universitaire de Nīmes (1) · National Cancer Institute (NCI) (1)
Italy (3) · United States (2) · France (1)
Giulia Martina Cavestro, MD, PhD (2)
UM1CA186709 (1), UM1CA186716 (1)